Cytomedix Inc (NASDAQOTH:CMXI)

CAPS Rating: 3 out of 5

A biotechnology company that develops and licenses autologous cellular therapies, including Cytomedix's proprietary AutoloGel(tm) Process to produce a platelet rich plasma gel for the treatment of wounds.

Results 1 - 6 of 6

Recs

0
Member Avatar NathanHamilton82 (< 20) Submitted: 2/21/2014 10:23:58 AM : Outperform Start Price: $0.51 CMXI Score: -30.17

Untapped market in regenerative wound healing boosted by CMS reimbursement rate decision in late 2013.

Recs

0
Member Avatar AndrewGreenBull (99.20) Submitted: 1/28/2014 12:02:08 PM : Outperform Start Price: $0.52 CMXI Score: -35.78

Thank you for bringing it up, Bravovevo! Not trying to be your opposite side, but they do have couple main catalysts in this year. I believe this is a good entry price

Recs

0
Member Avatar Haugurafpeningum (72.42) Submitted: 1/28/2014 9:19:38 AM : Outperform Start Price: $0.55 CMXI Score: -39.55

AndrewGreenBull

Recs

6
Member Avatar zzlangerhans (99.77) Submitted: 2/20/2013 11:42:39 PM : Outperform Start Price: $0.50 CMXI Score: -51.15

Cytomedix hit the 50 cent threshold today after a nasty looking dilutive financing. Other than hitting the threshold, I can't justify this green thumb so I'll let guest pitcher 50 Cent do the honors.

We're Cyto, raisin' some money
We gonna party, with some cash money
We getting our salary, from your money
And you know we don't care, it's not our money

You can buy up our stub, we know you're a scrub
We got a system called Angel, 451 is our drug
We're into getting paid, wanna get a hot tub
So come show us some love, if you like your stocks rough

Recs

3
Member Avatar lobnews (20.27) Submitted: 10/30/2007 1:51:34 PM : Outperform Start Price: $3.97 CMXI Score: -125.27

Seems interesting. spec play

Recs

1
Member Avatar SteadySaber (71.70) Submitted: 10/1/2007 7:01:11 PM : Outperform Start Price: $5.00 CMXI Score: -126.54

FDA approval. CMS catalysts. Wide open market. This stock is worth more then $114 million.

Results 1 - 6 of 6

Featured Broker Partners


Advertisement